The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
On any dips. But they don't appear to be too many. It's holding steady at 30+. As has been said before, it was pushed far too low, especially given the stage of the trials and the fact that so far there has not been anything adverse. Getting close now (H1) for 1a readout when we should hopefully see value inflexion.
Let's face it, the price was driven down and the placing price so low because of the financial distress Sareum was placed under by the River Fort deal.
With funding now sorted and 1a results to come, we're in a different place. RF will soon be gone.
It's good to see the continued buying, you're right, but there's always the backdrop of RF selling in quantity. If Sareum can find a way to exit their agreement (and pay then off effectively) the SP could look very different!
Yes, no shortage of buyers it seems. Just imagine if RF were put of the picture altogether, think it could rise quite rapidly (especially with 1a data etc). That said, there would have to be more cash raised to buy them out.
Biotech (and pharma more generally) is a costly business. It takes time and significant resources to get to clinical milestones. Sareun is on the cusp of one such milestone and now has the cash to pursue it. Let the trials complete (says Q2) and the data be presented. If it's as good as we hope then Sareum will be significantly undervalued (imo).
I think we need an end to the political turmoil and a new government with a fresh mandate. Not saying which side that'll be but I think the market needs renewed confidence in UK plc. I think that could see a change in fortunes as it's realised how much value there is! Here's hoping anyway.
Patent news is fantastic but there's uncertainty about finances right now after the Mon RNS and that's why the SP where it is. Lets see how the BOD plan a path out of this and hopefully 1a results show safety. Who knows, there may also be progression of 737.
Yes, it's good to hear they're open to it. Many existing shareholders, me included, want to support them through this. It's getting close to 1a results. With a decent raise m, and RF behind them, things could be looking quite different later in the year imo.